Literature DB >> 8665377

Insecticide-treated bednets reduce mortality and severe morbidity from malaria among children on the Kenyan coast.

C G Nevill1, E S Some, V O Mung'ala, W Mutemi, L New, K Marsh, C Lengeler, R W Snow.   

Abstract

New tools to prevent malaria morbidity and mortality are needed to improve child survival in sub-Saharan Africa. Insecticide treated bednets (ITBN) have been shown, in one setting (The Gambia, West Africa), to reduce childhood mortality. To assess the impact of ITBN on child survival under different epidemiological and cultural conditions we conducted a community randomized, controlled trial of permethrin treated bednets (0.5 g/m2) among a rural population on the Kenyan Coast. Between 1991 and 1993 continuous community-based demographic surveillance linked to hospital-based in-patient surveillance identified all mortality and severe malaria morbidity events during a 2-year period among a population of over 11000 children under 5 years of age. In July 1993, 28 randomly selected communities were issued ITBN, instructed in their use and the nets re-impregnated every 6 months. The remaining 28 communities served as contemporaneous controls for the following 2 years, during which continuous demographic and hospital surveillance was maintained until the end of July 1995. The introduction of ITBN led to significant reductions in childhood mortality (PE 33%, CI 7-51%) and severe, life-threatening malaria among children aged 1-59 months (PE 44%, CI 19-62). These findings confirm the value of ITBN in improving child survival and provide the first evidence of their specific role in reducing severe morbidity from malaria.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8665377     DOI: 10.1111/j.1365-3156.1996.tb00019.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  108 in total

1.  Insecticide treated bed nets to prevent malaria.

Authors:  U D'Alessandro
Journal:  BMJ       Date:  2001-02-03

Review 2.  Can anything be done to maintain the effectiveness of pyrethroid-impregnated bednets against malaria vectors?

Authors:  C F Curtis; J E Miller; M H Hodjati; J H Kolaczinski; I Kasumba
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1998-10-29       Impact factor: 6.237

3.  Coordinating health research to promote action: the Tanzanian experience.

Authors:  A Y Kitua; Y J Mashalla; J K Shija
Journal:  BMJ       Date:  2000-09-30

Review 4.  Improving child health: the role of research.

Authors:  F Dabis; J Orne-Gliemann; F Perez; V Leroy; M L Newell; A Coutsoudis; H Coovadia
Journal:  BMJ       Date:  2002-06-15

5.  Neglected diseases: under-funded research and inadequate health interventions. Can we change this reality?

Authors:  Carlos M Morel
Journal:  EMBO Rep       Date:  2003-06       Impact factor: 8.807

Review 6.  Child survival: district hospitals and paediatricians.

Authors:  M English
Journal:  Arch Dis Child       Date:  2005-09       Impact factor: 3.791

7.  Quality of care provided to febrile children presenting in rural private clinics on the Kenyan coast.

Authors:  T O Abuya; C S Molynuex; A S S Orago; S Were; V Marsh
Journal:  Afr Health Sci       Date:  2004-12       Impact factor: 0.927

8.  Does Insecticide Treated Mosquito Nets (ITNs) prevent clinical malaria in children aged between 6 and 59 months under program setting?

Authors:  Yunis Mussema Abdella; Amare Deribew; Wodwoson Kassahun
Journal:  J Community Health       Date:  2009-04

9.  The Blantyre Integrated Malaria Initiative: a model for effective malaria control.

Authors:  Mary J Hamel; Christopher Mkandala; Nyson Chizani; Nyokase Kaimilla; Jim Kublin; Richard Steketee
Journal:  Malawi Med J       Date:  2002-04       Impact factor: 0.875

10.  Parasite burden and severity of malaria in Tanzanian children.

Authors:  Bronner P Gonçalves; Chiung-Yu Huang; Robert Morrison; Sarah Holte; Edward Kabyemela; D Rebecca Prevots; Michal Fried; Patrick E Duffy
Journal:  N Engl J Med       Date:  2014-05-08       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.